作者
Kimmo Virtaneva, Elena D'Amato, Jinmin Miao, Marjaleena Koskiniemi, Reijo Norio, Giuliano Avanzini, Silvana Franceschetti, Roberto Michelucci, Carlo A Tassinari, Salah Omer, Len A Pennacchio, Richard M Myers, José L Dieguez-Lucena, Ralf Krahe, Albert de la Chapelle, Anna-Elina Lehesjoki
发表日期
1997/4/1
期刊
Nature genetics
卷号
15
期号
4
页码范围
393-396
出版商
Nature Publishing Group US
简介
Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1; MIM 254800) is an autosomal recessive disorder that occurs with a low frequency in many populations but is more common in Finland and the Mediterranean region1,2. It is characterized by stimulus-sensitive myoclonus and tonic-clonic seizures with onset at age 6–15 years, typical electroencephalographic abnormalities and a variable rate of progression between and within families3–5. Following the initial mapping of the EPM1 gene to chromosome 21 (ref. 6) and the refinement of the critical region to a small interval7–9, positional cloning identified the gene encoding cystatin B (C5T6), a cysteine protease inhibitor, as the gene underlying EPM1 (ref. 10). Levels of messenger RNA encoded by CST6 were dramatically decreased in patients. A 3′ splice site and a stop codon mutation were identified in three families, leaving most mutations …
引用总数
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024111222151717121611113854858452110252341
学术搜索中的文章